Liu JM, Lin CY, Chuang HC, & Hsu RJ. (2018). No increased risk of psoriasis in patients receiving androgen deprivation therapy for prostate cancer: A 17-year population-based study. Dove Medical Press.
Chicago Style (17th ed.) CitationLiu JM, Lin CY, Chuang HC, and Hsu RJ. No Increased Risk of Psoriasis in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer: A 17-year Population-based Study. Dove Medical Press, 2018.
MLA (9th ed.) CitationLiu JM, et al. No Increased Risk of Psoriasis in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer: A 17-year Population-based Study. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.